[go: up one dir, main page]

WO2012025730A3 - Soluble film - Google Patents

Soluble film Download PDF

Info

Publication number
WO2012025730A3
WO2012025730A3 PCT/GB2011/051439 GB2011051439W WO2012025730A3 WO 2012025730 A3 WO2012025730 A3 WO 2012025730A3 GB 2011051439 W GB2011051439 W GB 2011051439W WO 2012025730 A3 WO2012025730 A3 WO 2012025730A3
Authority
WO
WIPO (PCT)
Prior art keywords
soluble film
film
soluble
simethicone
making
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2011/051439
Other languages
French (fr)
Other versions
WO2012025730A2 (en
Inventor
Andrew Ingram
Alan Gibson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biofilm Ltd
Original Assignee
Biofilm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofilm Ltd filed Critical Biofilm Ltd
Publication of WO2012025730A2 publication Critical patent/WO2012025730A2/en
Publication of WO2012025730A3 publication Critical patent/WO2012025730A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

There is herein described a soluble film. More particularly, there is described a soluble film comprising simethicone and a method of making such a film.
PCT/GB2011/051439 2010-08-23 2011-07-29 Soluble film Ceased WO2012025730A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1014041.6A GB201014041D0 (en) 2010-08-23 2010-08-23 Soluble film
GB1014041.6 2010-08-23

Publications (2)

Publication Number Publication Date
WO2012025730A2 WO2012025730A2 (en) 2012-03-01
WO2012025730A3 true WO2012025730A3 (en) 2012-07-26

Family

ID=42984487

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2011/051439 Ceased WO2012025730A2 (en) 2010-08-23 2011-07-29 Soluble film

Country Status (2)

Country Link
GB (1) GB201014041D0 (en)
WO (1) WO2012025730A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9381248B2 (en) 2010-08-31 2016-07-05 Toray Industries, Inc. Coating agent for pharmaceutical solid preparation, pharmaceutical film formulation, and coated pharmaceutical solid preparation
US10829621B2 (en) 2013-01-11 2020-11-10 Monosol, Llc Edible water-soluble film
KR102839902B1 (en) * 2018-11-05 2025-07-29 인스파이어드 머티리얼 스트래티지스, 엘엘씨 Dimethicone-based oral varnish

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003030882A1 (en) * 2001-10-12 2003-04-17 Kosmos Pharma Thin film with non-self-aggregating uniform heterogeneity, process for their production and drug delivery systems made thereform
US20080044454A1 (en) * 2002-04-11 2008-02-21 Monosolrx Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20080292683A1 (en) * 2007-05-24 2008-11-27 Monosolrx, Llc. Film shreds and delivery system incorporating same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073384A (en) 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US7341742B2 (en) 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
WO2005040228A2 (en) 2003-10-24 2005-05-06 Adhesives Research, Inc. Disintegratable films for diagnostic devices

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003030882A1 (en) * 2001-10-12 2003-04-17 Kosmos Pharma Thin film with non-self-aggregating uniform heterogeneity, process for their production and drug delivery systems made thereform
US20080044454A1 (en) * 2002-04-11 2008-02-21 Monosolrx Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20080292683A1 (en) * 2007-05-24 2008-11-27 Monosolrx, Llc. Film shreds and delivery system incorporating same

Also Published As

Publication number Publication date
GB201014041D0 (en) 2010-10-06
WO2012025730A2 (en) 2012-03-01

Similar Documents

Publication Publication Date Title
WO2011133504A3 (en) Nanozymes, methods of making nanozymes, and methods of using nanozymes
WO2013046060A9 (en) Paper and methods of making paper
WO2012006616A3 (en) Intraocular lens delivery devices and methods of use
WO2012084126A3 (en) Formulation of lacosamide
WO2011146155A3 (en) Organo-metallic frameworks derived from carbenophilic metals and method of making same
EP2560048A4 (en) Self-supporting film, self-supporting structure, method for manufacturing self-supporting film, and pellicle
WO2010148374A3 (en) Organo-metallic frameworks and methods of making same
EP2467173B8 (en) Wound dressings, methods of using the same and methods of forming the same
EP2629975A4 (en) Devices, systems, and methods for the fabrication of tissue
WO2012100224A3 (en) Preparation of metal-triazolate frameworks
EP2667810A4 (en) Ultrasonic surgical instrument, associated surgical method and related manufacturing method
EP2526637A4 (en) Voice transmission technology selection
WO2010081036A3 (en) Fluorine containing compounds and methods of use thereof
EP2562940A4 (en) Method for cooperative data transmission among terminals, and method for clustering cooperative terminals for same
WO2012001371A8 (en) Provision of wound filler
EP2534806A4 (en) Integrated multi-datastream transmission technology
WO2012051117A3 (en) Substituted benzamides and their uses
WO2012082517A3 (en) Controlled degradation fibers
EP2592730A4 (en) Cage rotor, and cage rotor manufacturing method
EP2589633A4 (en) Film for tire inner liner, and preparation method thereof
EP2537956A4 (en) Thin film manufacturing apparatus, thin film manufacturing method, and method for maintaining thin film manufacturing apparatus
WO2013048177A3 (en) Selenophene-fused aromatic compound and manufacturing method thereof
WO2012087327A3 (en) Polymer systems
WO2010081034A3 (en) Fluorine containing compounds and methods of use thereof
EP2623822A4 (en) Spherical annular seal member, and method for producing same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11745816

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11745816

Country of ref document: EP

Kind code of ref document: A2